MERRIMACK PHARMACEUTICALS INC Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Merrimack Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Merrimack Pharmaceuticals Inc Operating Income (Loss) for the quarter ending March 31, 2024 was -$669K, a 49.7% decline year-over-year.
  • Merrimack Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending March 31, 2024 was -$2.26M, a 10.5% decline year-over-year.
  • Merrimack Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was -$2.04M, a 17.8% decline from 2022.
  • Merrimack Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$1.73M, a 30.1% increase from 2021.
  • Merrimack Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$2.47M, a 14% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2.04M -$308K -17.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 -$1.73M +$743K +30.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 -$2.47M +$401K +14% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$2.87M +$19.5M +87.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 -$22.4M +$43.2M +65.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-10
2018 -$65.6M +$30.2M +31.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 -$95.8M +$51.6M +35% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 -$147M -$2.25M -1.55% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-12
2015 -$145M -$115M -387% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 -$29.8M +$90.8M +75.3% Jan 1, 2014 Dec 31, 2014 8-K 2017-12-15
2013 -$121M -$27.8M -30% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
2012 -$92.7M -$11.9M -14.7% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
2011 -$80.9M -$31.7M -64.4% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-04
2010 -$49.2M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.